bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.993
-0.187 (-15.86%)
At close: Dec 20, 2024, 4:00 PM
1.010
+0.017 (1.73%)
After-hours: Dec 20, 2024, 6:37 PM EST
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $15.47 million as of December 20, 2024. Its market cap has increased by 7.12% in one year.
Market Cap
15.47M
Enterprise Value
16.44M
1-Year Change
7.12%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $15.47M, a decrease of -65.61%. That is a compound annual growth rate of -37.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 15.47M | 10.73% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbot Medical | 16.50M |
| Inspira Technologies Oxy B.H.N. | 16.47M |
| Nephros | 16.24M |
| Unity Biotechnology | 16.17M |
| The Oncology Institute | 15.87M |
| Traws Pharma | 15.19M |
| Minerva Neurosciences | 15.11M |
| GlycoMimetics | 15.08M |